Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 3, 1997

View Archived Issues

New CNS agents with 5-HT2C-antagonist activity from Fujisawa

Allergan continues research into retinoids and retinoid-like compounds

Neurocrine Bioscience's CRF antagonists for stress-related disorders

Japanese researchers describe compounds for lipoprotein disorders

Anti-HIV agents from Shionogi

NOS inhibitors described by JT

Sankyo prepares prostaglandin derivatives for ulcers

Hypoglycemic/hypolipidemic agents from Sumitomo Metal

Novel series with anti-HIV and antimalarial activity

Aronex describes anti-HCMV compound

Gilead selects GS-930 prodrug for further evaluation

PMPA prodrug selected as clinical candidate

Anti-HIV agent that targets NCp7 zing fingers

British scientists describe novel therapeutic approach to HIV

Ganciclovir prodrug shows potential for treatment of CMV retinitis

Preliminary efficacy and safety data for an HIV therapeutic vaccine

Memorial Sloan-Kettering and Sequana form cancer joint venture

Inhale/Lilly collaborate on pulmonary delivery of osteoporosis Rx

Structural Bioinformatics and CyberChemics collaborate on viral protease inhibitors

Successful completion of phase I trial of aerosolized osteoporosis product

Preclinical results indicate potential of new approach to treatment of solid tumors

Companies aim for development of rapid one-step HIV urine test

Arthritis test enters clinic

Gene causing glaucoma located and cloned

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...